Shopping Cart 0
Cart Subtotal
USD 0

Endo International Plc (ENDP)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Endo International Plc (ENDP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies including Endo Pharmaceuticals, Paladin Labs, Par Pharmaceutical, Litha and SOMAR. It sells generic products principally in the US across multiple therapeutic categories, comprising urology, pain management, central nervous system (CNS) disorders, immunosuppression, cancer, cardiovascular diseases and women's health markets, among others. The company's branded pharmaceuticals target urology, orthopedics/pediatric endocrinology and pain management markets. Endo also provides over-the-counter (OTC) products across key market segments comprising dermatology and anti-infectives. The company sells its products through independent wholesale distributors, as well as to retailers, government agencies, doctors, clinics, independent retail and specialty pharmacies and independent specialty distributors. Endo is headquartered in Dublin, Ireland.

Endo International Plc Key Recent Developments

Feb 28,2017: Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results

Jan 26,2017: Endo Announces Actions to Drive Greater Efficiency and Business Alignment

Dec 21,2016: Endo Announces Appointments and Updates to Executive Management Team

Dec 20,2016: Endo Announces Appointment of Blaise Coleman as Chief Financial Officer

Nov 08,2016: Endo Reports Third Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Endo International Plc-Key Facts 6

Endo International Plc-Key Employees 7

Endo International Plc-Key Employee Biographies 9

Endo International Plc-Major Products and Services 11

Endo International Plc-Pharmaceutical Pipeline Products Data 13

Endo International Plc, Pipeline Products by Therapy Area 13

Endo International Plc-History 13

Endo International Plc-Company Statement 19

Endo International Plc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Section 2-Company Analysis 22

Endo International Plc-Business Description 22

Endo International Plc-Corporate Strategy 23

Endo International Plc-SWOT Analysis 24

SWOT Analysis-Overview 24

Endo International Plc-Strengths 24

Endo International Plc-Weaknesses 25

Endo International Plc-Opportunities 26

Endo International Plc-Threats 27

Endo International Plc-Key Competitors 28

Section 3-Company Financial Ratios 29

Financial Ratios-Capital Market Ratios 29

Financial Ratios-Annual Ratios 30

Performance Chart 32

Financial Performance 32

Financial Ratios-Interim Ratios 33

Financial Ratios-Ratio Charts 34

Section 4-Company's Lifesciences Financial Deals and Alliances 35

Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 35

Endo International Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 36

Endo International Plc, Recent Deals Summary 37

Section 5-Company's Recent Developments 38

Feb 28, 2017: Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results 38

Jan 26, 2017: Endo Announces Actions to Drive Greater Efficiency and Business Alignment 41

Dec 21, 2016: Endo Announces Appointments and Updates to Executive Management Team 42

Dec 20, 2016: Endo Announces Appointment of Blaise Coleman as Chief Financial Officer 43

Nov 08, 2016: Endo Reports Third Quarter 2016 Financial Results 44

Nov 07, 2016: Endo Strengthens Leadership Team with Appointment of Two Key Executives 46

Oct 20, 2016: Endo Announces Departure of Chief Financial Officer 47

Sep 23, 2016: Endo Names Paul Campanelli President and Chief Executive Officer 48

Aug 08, 2016: Endo Reports Second Quarter 2016 Financial Results 49

Aug 08, 2016: Endo Announces Appointment of Joseph J. Ciaffoni as President, U.S. Branded Pharmaceuticals 51

Section 6-Appendix 52

Methodology 52

Ratio Definitions 52

About GlobalData 56

Contact Us 56

Disclaimer 56


List Of Figure

List of Tables

Endo International Plc, Key Facts 6

Endo International Plc, Key Employees 7

Endo International Plc, Key Employee Biographies 9

Endo International Plc, Major Products and Services 11

Endo International Plc, History 13

Endo International Plc, Other Locations 20

Endo International Plc, Subsidiaries 20

Endo International Plc, Key Competitors 28

Endo International Plc, Ratios based on current share price 29

Endo International Plc 30

Endo International Plc (Cont...1) 31

Endo International Plc, Interim Ratios 33

Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 35

Endo International Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 36

Endo International Plc, Recent Deals Summary 37

Currency Codes 52

Capital Market Ratios 52

Equity Ratios 53

Profitability Ratios 53

Cost Ratios 54

Liquidity Ratios 54

Leverage Ratios 55

Efficiency Ratios 55


List Of Table

List of Figures

Endo International Plc, Pipeline Products by Therapy Area 13

Endo International Plc, Performance Chart (2012-2016) 32

Endo International Plc, Ratio Charts 34

Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 35

Endo International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 36

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Endo International Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Shire Plc Purdue Pharma LP Mallinckrodt Plc Jazz Pharmaceuticals Plc Horizon Pharma Plc Allergan Plc Abbott Laboratories